Member Info for LTbeliever

I have just noticed, on the same (beginning of page 3) OFWAT update that there is another "challenge", also potentially well suited to MET i.e. "PFAS - A whole system approach to an impossible problem"; coincidentally, this is also run by Severn Trent Water, deadline 30/04/2027; so we could get news on PFAS detection in water too, with a bit of luck next year?

Very interesting NickTS, thanks. Reference to "Ofwat Breakthrough Challenge for Cryptosporidium" as well; deadline is Aug. 2028 so MET could have a head start in early Jan for commercial deployment (see 2nd half of page 3).

https://waterinnovation.challenges.org/wp-content/uploads/sites/3/2026/04/Water-Innovation-Fund-Project-dates-March-2026-5.pdf

Income projections are realistic too - FY26E: Revenue £3.50m (FCF: £0.20m) Breakeven/EBITDA positive

FY27E: Revenue £5.50m (FCF: £0.60m), FY28E: Revenue £8.00m (FCF: £1.20m, FCF Margin 15%)

And finally, article makes zero mention to SRB kits and MEast potential with the Saudis and Emiratis doubling their pipelines' capacity due to the war. Should the AFS 2025 and 2026 outlook be positive w/o any nasty surprises on cash, margins, sales etc then it'll be a good launchpad - by next week hopefully.

Warrants are option-like i.e. the value lies in waiting at the latest possible moment to exercise them; why spend money now, if you can exercise in 2-3 etc years? If you use your cash today and the SP crashes, then you lose out by not waiting.

Https://www.turnerpope.com/wp-content/uploads/2026/03/Metirplc_AptamerGroupplc_17-2-2026_FINAL_BG.pdf

FFX finally averaging down??

Maybe Dan-Ringlet-French? :)

:)))))))) I am sure you'll be back tomorrow. BTW, now we know why Dan skipped Florida - he was in France :)))))

FFX, I advised against reading, we don't want you to get too excited :))))) we want your negativity on the BB, it's refreshing.

Thanks for the reminder - some useful links and a ramping alert (FFX, don't read any further :) ); Dan is a Director here but see who the other Directors are - 2 are big venture capital entities, investing - among others - in pharma start ups etc; one of these start ups (last link) is looking for a cure relating to Neurofibromatosis etc; is it unrealistic to consider that NFX too is talking to these people and/or going to work with one of these small pharmas after getting some money from these Inst. Investors? Why is it a negative, and not a positive for NFX that Dan is a Director here too? Synergies are quite possible.

https://find-and-update.company-information.service.gov.uk/company/16119573/officers

https://www.generalinception.com/companies

https://www.deepscienceventures.com/

https://www.cureagetx.com/

FFX, if I had 1mln to give to Dan, I could ask anything I wanted eg no TR1 by spreading it around various Nominee entities; 1mln was around 25% of the capital so the buyer used maybe a dozen entities to keep it under the 3% threshold; if "they sold quickly", someone else bought that 25%, could be many PIs but still, they bought, right?

You have every right to buy more shares and average down; or sell out and cut your losses; instead you hold on to a massive loss and express your exasperation here on a daily basis as if it will change anything; whatever we write is not convincing for you because you are seeking confirmation of your negative thoughts; real deals take time, NFX is a taker (beggars cannot be choosers) so if - as Soup is saying - someone will pay NFX 15-20mln they have every right to take their time and expect confidentiality - if you don't understand this, nothing we say will change your viewpoint.

Soup, thanks; it seems to me that we can huff and puff all we want (PnDers + naysayers) but until the studies start producing the results - hopefully - expected by the "potential" partners, we are in limbo (unless Dan produces a rabbit in the form of a deal before those studies are concluded). My comfort -FWIW - is that someone with plenty of money and options to invest decided 10 weeks ago to give Dan 1mln, on the promise of nothing basically and despite Dan's "atrocious" record of BS RNSs, as detailed here by various unhappy holders.

One more thing pls - your pharma sales' mate has made - it appears - a generic comment about "if the revenue targets were lower than the companies targets then they would not invest"; are you saying you know both all big pharmas' targets AND NPX2 revenue projections? Why did NFX issue an RNS referring to both big and small pharma in March? To mislead the market and the new investors?

THaven, thanks for adding more meat to your argument, hopefully Soup can answer; in the meantime, however, is 9 weeks (since FDA ODD) enough time to definitively conclude that even small pharma is not interested? Studies are still being conducted and negotiating deals takes time, especially if lawyers need to be involved - 9 weeks is around 40 working days (excl Easter holidays etc). And ignoring your usual assertion that for Dan, this is just "luxury lifestyle" and not a FT job.

Co can't reveal anything until the dotted line is signed; and getting a signature is - mostly - out of the Co's control so how can they reveal something that does not yet exist? 2 months FFX, then you can yell at us as much as you like - and post non-stop.

Thanks Soup; I'd add, negative noise for the sake of noise.

FWIW, my take on Dan not attending the conference is simply because he doesn't need to talk to multiple parties re NPX2's promotion, as NFX is currently working on closing the deals with its few selected partners, as soon as the studies are concluded (or before) - I might be wrong of course, alternative theories welcome!

Soup, hi; I'd be very interested to hear your view about this assertion by TH " "If no one is interested in taking NXP002 to market due to lack of revenue projections ...." with NPX002 still being at the pre-clinical stage; what's the normal market way forward, pls?

NP FFX, we all want to make money out of NFX, we just have different views about the present and the future; some rely on the past to guide them, whether they are right or wrong only time will tell; I say 2 months or so*** and the truth will shine - DYOR

***(because the new investor/s who chipped 1mln in, is not the type to hang around for another 10 years)

Tnx FFX, tb honest I had you in the "cynical long term holders" category, not the bitter ones :)))

THaven, you make absolute statements but these sound quite biased; just the opposite of what you say actually e.g. "PnDers love it though as it is easy to create false narratives without any come back.." - what about bitter long term holders? why should we assume they are not negatively biased?

You keep repeating that "NFX is a lifestyle supplement for Dan and others". where do you base this??? Dan skipped a free trip to Florida, he earns 30.000p.a. (of which 5.000 is accrued, as per latest AFS), whereas the other 2 Directors are due 200% of their annual 30k salaries; do you even read the AFS?

and how do you know "If no one is interested in taking NXP002 to market due to lack of revenue projections ...."? How can revenue be projected at the pre-clinical stage? Before even the additional studies are concluded etc?